Helen Gogas
National and Kapodistrian University of Athens(GR)Laiko General Hospital of Athens(GR)Frontier Science Foundation-Hellas(GR)Athens State University(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, CAR-T cell therapy research, Cutaneous Melanoma Detection and Management, Immunotherapy and Immune Responses
Most-Cited Works
- → Nivolumab in Previously Untreated Melanoma without BRAF Mutation(2014)5,311 cited
- → Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma(2017)2,174 cited
- → Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma(2014)1,843 cited
- → Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial(2015)1,372 cited
- → Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma(2019)1,338 cited
- → Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma(2019)1,063 cited